Funds performance table by strategy

help icon
fund name 1 mth 3 mth 12 mth ytd Inceptionsort icon Net assets Return Date
SEB Global IC 3% 10% 34% 34% 28% 4295M 2014-12-31
Cumulus Energy Fund -3% 1% 19% 17% 28% - 2014-08-31
Bellevue(Lux) BB Biotech I EUR 2% 17% 56% 56% 28% 59M 2014-12-31
Monashee Capital Partners LP 3% 5% 32% 10% 28% - 2014-08-31
SPDR® S&P World ex Australia ETF 2% 7% 13% 13% 28% - 2014-12-31
Vanguard Extended Dur Trs Idx InstlPlus 5% 14% 45% 45% 28% - 2014-12-31
Numen Credit Opportunities Fund 0% 0% 2% 2% 28% - 2014-12-31
AMG Managers Emerging Opps Instl 4% 12% 2% 2% 28% - 2014-12-31
OYSTER European Selection R EUR 1% -1% 20% 3% 28% - 2014-05-31
Hanwha PensSav Glbl Healthcare Fdr Eq Ce -1% 6% 27% 27% 28% 4295M 2014-12-31
AAA Pinpoint Plus Fund A 2% 5% 7% 6% 28% - 2014-11-30
Dzaner & Co. LP 1% -1% 16% -4% 28% 1M 2014-08-31
ICICI Pru SMART Ser G 36 Mn Retl Div 0% -4% 5% -3% 28% 126M 2011-07-31
ICICI Pru SMART Ser G 36 Mn Retl Gr 0% -4% 5% -3% 28% 126M 2011-07-31
Nedgroup Inv Global Flexible FF B2 4% 4% 16% 16% 28% 1894M 2014-12-31
Grindrod Global Property Income C 7% 14% 35% 35% 28% 282M 2014-12-31
CF Miton UK Smaller Companies B Acc 0% -3% 1% 1% 28% 149M 2014-12-31
Reitway BCI Global Property B 6% 10% 23% 23% 28% 1257M 2014-12-31
Strategic Advisers® S-M Cp Multi-Mgr F 0% 1% 22% 1% 28% - 2014-03-31
ZKB-IPF North America Real Estate Idx N 4% 17% 43% 43% 28% - 2014-12-31
HorizonsBetaPro NYMEX NatrlGas Bear+ ETF 84% 85% 9% 9% 28% 35M 2014-12-31
Neptune UK Mid Cap B 5% 8% 27% 5% 28% 167M 2014-01-31
NVIT Small Cap Index II 0% 1% 0% 1% 28% - 2014-03-31
Candriam Eqs L Biotechnology I USD Acc 0% 13% 36% 36% 28% 712M 2014-12-31
Nordea-1 Global Opportunity BI NOK 5% 17% 0% 0% 28% 440M 2014-12-31
Amundi Fds Eq Japan Target IHE-C 2% 4% 15% 15% 28% 163M 2014-12-31
UBS Lux Inst SICAV II China A Opp P Acc 19% 0% 0% 0% 28% 833M 2014-12-31
Templeton Asian Smaller Co I Acc € 3% 1% 24% 24% 28% 1037M 2014-12-31
PIMCO GIS US Fdmtl Idx StkPLUS Ins € Acc 2% 9% 29% 29% 28% 355M 2014-12-31
Mackenzie US Lg Cap Cl E 5% 8% 34% 31% 27% 324M 2013-10-31

All our data is licensed from Morningstar UK Ltd. Important legal information